Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Acro Biomedical (ACBM) Gross Profit (2017 - 2022)

Acro Biomedical (ACBM) has 6 years of Gross Profit data on record, last reported at $64000.0 in Q4 2022.

  • For Q4 2022, Gross Profit fell 57.33% year-over-year to $64000.0; the TTM value through Sep 2023 reached $64000.0, down 71.74%, while the annual FY2022 figure was $140500.0, 45.86% down from the prior year.
  • Gross Profit reached $64000.0 in Q4 2022 per ACBM's latest filing, down from $76500.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $252600.0 in Q3 2018 and bottomed at $12096.0 in Q4 2019.
  • Average Gross Profit over 5 years is $126890.9, with a median of $135400.0 recorded in 2018.
  • Peak YoY movement for Gross Profit: tumbled 91.07% in 2019, then skyrocketed 159.32% in 2022.
  • A 5-year view of Gross Profit shows it stood at $135400.0 in 2018, then crashed by 91.07% to $12096.0 in 2019, then skyrocketed by 1217.82% to $159404.0 in 2020, then fell by 5.9% to $150000.0 in 2021, then plummeted by 57.33% to $64000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $64000.0 in Q4 2022, $76500.0 in Q1 2022, and $150000.0 in Q4 2021.